Page 4 - Butt Paste News Today

Prestige Consumer Healthcare (NYSE:PBH – Get Rating) announced its quarterly earnings results on Thursday. The company reported $1.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.04 by $0.03, Briefing.com reports. Prestige Consumer Healthcare had a net margin of 18.97% and a return on equity of 12.65%. The business had revenue […]

Revenue of $285.9 Million in Q4 and $1,127.7 Million in Fiscal 2023Organic Revenue Grew 8.0% in Q4 and 3.5% in Fiscal 2023Achieved Leverage Ratio of 3.3x at Year End; Revising Long-term Leverage... | May 4, 2023

Prestige Consumer Healthcare (NYSE:PBH – Get Rating) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $4.27-$4.32 for the period, compared to the consensus estimate of $4.18. The company issued revenue guidance of $1.14 billion-$1.14 billion, compared to the consensus revenue estimate of […]

Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating) – Investment analysts at Oppenheimer reduced their Q1 2024 earnings per share (EPS) estimates for Prestige Consumer Healthcare in a note issued to investors on Monday, April 24th. Oppenheimer analyst R. Parikh now forecasts that the company will earn $1.06 per share for the quarter, down from […]

Olstein Capital Management L.P. lowered its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating) by 13.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 47,665 shares of the company’s stock after selling 7,335 shares during the quarter. Olstein Capital Management […]

Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating) has been given a consensus recommendation of “Moderate Buy” by the seven research firms that are currently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month […]

Smith Graham & Co. Investment Advisors LP lowered its position in Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating) by 0.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 149,505 shares of the company’s stock after selling 517 shares during […]

Leeward Investments LLC MA lowered its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating) by 0.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 541,722 shares of the company’s stock after selling 3,115 shares during the quarter. Prestige Consumer […]

M&G Investment Management Ltd. grew its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating) by 83.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 53,313 shares of the company’s stock after buying an additional 24,236 shares during the […]

Rice Hall James & Associates LLC decreased its position in Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating) by 0.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 626,159 shares of the company’s stock after selling 841 shares during the quarter. Prestige Consumer […]